Stockscreener 앱 받기
4.031
8.22%
-0.349
시간 외 거래:
4.04
0.009
+0.22%
전일 마감가:
$4.38
열려 있는:
$4.3
하루 거래량:
54,903
Relative Volume:
0.05
시가총액:
$6.62M
수익:
$12.31M
순이익/손실:
$-5.08M
주가수익비율:
-4.2883
EPS:
-0.94
순현금흐름:
$-5.20M
1주 성능:
+0.75%
1개월 성능:
-14.10%
6개월 성능:
+93.27%
1년 성능:
+34.00%
1일 변동 폭
$4.01
$4.3034
1주일 범위
$4.01
$4.60
52주 변동 폭
$1.75
$6.9199
소노마 파머 Stock (SNOA) Company Profile
명칭
Sonoma Pharmaceuticals Inc
전화
800-759-9305
주소
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
SNOA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
4.031 | 7.23M | 12.31M | -5.08M | -5.20M | -0.94 |
|
ZTS
Zoetis Inc
|
141.09 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
439.99 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
소노마 파머 주식(SNOA)의 최신 뉴스
Sonoma Pharmaceuticals Inc. recovery potential after sell off2025 Price Momentum & Risk Controlled Daily Trade Plans - newser.com
Using RSI to spot recovery in Sonoma Pharmaceuticals Inc.2025 Key Lessons & Weekly Watchlist for Hot Stocks - newser.com
Is Sonoma Pharmaceuticals Inc. stock attractive for long term wealth buildingEarnings Summary Report & Intraday High Probability Setup Alerts - newser.com
Why Sonoma Pharmaceuticals Inc. (O8Z) stock is favored by hedge fundsJuly 2025 Intraday Action & Capital Efficient Trading Techniques - newser.com
Will Sonoma Pharmaceuticals Inc. rebound enough to break even2025 Price Momentum & Community Driven Trade Alerts - newser.com
Analyzing Sonoma Pharmaceuticals Inc. with risk reward ratio chartsEarnings Beat & Technical Pattern Alert System - newser.com
Tools to assess Sonoma Pharmaceuticals Inc.’s risk profileJuly 2025 Action & Risk Managed Trade Strategies - newser.com
Real time scanner hits for Sonoma Pharmaceuticals Inc. explainedRate Hike & AI Powered Buy and Sell Recommendations - newser.com
How Sonoma Pharmaceuticals Inc. stock performs in interest rate cycles2025 Trading Recap & AI Enhanced Trading Signals - newser.com
Sonoma Pharmaceuticals’ (SNOA) Sell (D-) Rating Reiterated at Weiss Ratings - Defense World
How institutional ownership impacts Sonoma Pharmaceuticals Inc. stockGold Moves & Short-Term Trading Alerts - newser.com
Sonoma Pharmaceuticals (SNOA) Expands Reach with FDA Cosmetic Re - GuruFocus
Sonoma Pharmaceuticals registers under FDA’s cosmetics act - Investing.com
Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA - ACCESS Newswire
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Sees Large Drop in Short Interest - Defense World
Can Sonoma Pharmaceuticals Inc. stock reach $100 price targetTrade Analysis Report & Verified Entry Point Signals - newser.com
Real time alert setup for Sonoma Pharmaceuticals Inc. performance2025 Short Interest & Real-Time Volume Triggers - newser.com
Is Sonoma Pharmaceuticals Inc. showing signs of accumulationBuy Signal & Breakout Confirmation Trade Signals - newser.com
Analyzing drawdowns of Sonoma Pharmaceuticals Inc. with statistical toolsWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Can Sonoma Pharmaceuticals Inc. (O8Z) stock sustain double digit ROEQuarterly Trade Review & Real-Time Volume Surge Alerts - newser.com
Is Sonoma Pharmaceuticals Inc. (O8Z) stock trading at attractive multiples2025 Volume Leaders & Long-Term Growth Stock Strategies - newser.com
Using fundamentals and technicals on Sonoma Pharmaceuticals Inc.July 2025 Outlook & Precise Trade Entry Recommendations - newser.com
Developing predictive dashboards with Sonoma Pharmaceuticals Inc. dataJuly 2025 Action & Weekly Return Optimization Alerts - newser.com
Sonoma Pharmaceuticals Highlights Growth in Healthcare Sector - TipRanks
Published on: 2025-09-29 12:26:08 - newser.com
소노마 파머 (SNOA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.54%
1.16%
자본화:
|
볼륨(24시간):